Targeting of the WT1 91–138 Fragment to Human Dendritic Cells Improves Leukemia-Specific T-cell Responses Providing an Alternative Approach to WT1-based Vaccination

Nergui Dagvadorj,Anne Deuretzbacher,Daniela Weisenberger,Elke Baumeister,Johannes Trebing,Isabell Lang,Carolin Köchel,Markus Kapp,Kerstin Kapp,Andreas Beilhack,Thomas Hünig,Hermann Einsele,Harald Wajant,Götz Ulrich Grigoleit

Cancer Immunology, Immunotherapy（2017）

引用 0|浏览1

关键词

Wilms tumor protein 1,Tumor-associated antigen,Immunotherapy against high-risk AML,Anti-hDEC205-WT1 antibody fusion protein,Cytotoxic T-cells,Tumor vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要